RDY 596 (Memantine hydrochloride 5 mg)
Pill imprint RDY 596 has been identified as Memantine hydrochloride 5 mg.
Memantine is used in the treatment of alzheimer's disease; migraine; autism and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 596
- Strength:
- 5 mg
- Color:
- Orange
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Major Pharmaceuticals
More about memantine
Consumer resources
- Memantine
- Memantine extended-release capsules
- Memantine solution
- Memantine tablets
- Memantine (Advanced Reading)
- Other brands: Namenda, Namenda XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
